1 |
SANAI N, ALVAREZ‑BUYLLA A, BERGER M S. Neural stem cells and the origin of gliomas[J]. N. Engl. J. Med., 2005, 353(8): 811-822.
|
2 |
SCHWARTZBAUM J A, FISHER J L, ALDAPE K D, et al.. Epidemiology and molecular pathology of glioma[J]. Nat. Clin. Pract. Neurol., 2006, 2(9): 494-503.
|
3 |
CLOUGHESY T F, CAVENEE W K, MISCHEL P S. Glioblastoma: from molecular pathology to targeted treatment[J]. Annu. Rev. Pathol., 2014, 9(9): 1-25.
|
4 |
WEN P Y, WELLER M, LEE E Q, et al.. Glioblastoma in adults: a society for neuro-oncology (SNO) and european society of neuro-oncology (EANO) consensus review on current management and future directions[J]. Neuro. Oncol., 2020, 22(8): 1073-1113.
|
5 |
LOUIS D N, OHGAKI H, WIESTLER O D, et al.. The 2007 WHO classification of tumours of the central nervous system[J]. Acta. Neuropathol., 2007, 114(2): 97-109.
|
6 |
NEWLANDS E S, STEVENS M F, WEDGE S R, et al.. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials[J]. Cancer Treat. Rev., 1997, 23(1): 35-61.
|
7 |
ARORA A, SOMASUNDARAM K. Glioblastoma vs temozolomide: can the red queen race be won?[J]. Cancer Biol. Ther., 2019, 20(8): 1-8.
|
8 |
CHRISTMANN M, KAINA B. Epigenetic regulation of DNA repair genes and implications for tumor therapy[J]. Mutat. Res. Rev. Mutat. Res., 2017, 780: 15-28.
|
9 |
SRIVENUGOPAL K S, YUAN X H, FRIEDMAN H S, et al.. Ubiquitination-dependent proteolysis of O6-methylguanine-DNA methyltransferase in human and murine tumor cells following inactivation with O6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea[J]. Biochemistry, 1996, 35(4): 1328-1334.
|
10 |
XU-WELLIVER M, Pegg A E. Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase[J]. Carcinogenesis, 2002, 23(5): 823-830.
|
11 |
LIM A, LI B F. The nuclear targeting and nuclear retention properties of a human DNA repair protein O6-methylguanine-DNA methyltransferase are both required for its nuclear localization: the possible implications[J]. Embo. J., 1996, 15(15): 4050-4060.
|
12 |
MARGISON G P, POVEY A C, KAINA B, et al.. Variability and regulation of O6-alkylguanine-DNA alkyltransferase[J]. Carcinogenesis, 2003, 24(4): 625-635.
|
13 |
KAINA B, CHRISTMANN M, NAUMANN S, et al.. MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents[J]. DNA Repair, 2007, 6(8): 1079-1099.
|
14 |
WICKSTR M M, DYBERG C, MILOSEVIC J, et al.. Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance [J/OL]. Nat. Commun., 2015, 6: 8904[2021-09-30]. .
|
15 |
GROMBACHER T, KAINA B. Constitutive expression and inducibility of O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in rat liver cells exhibiting different status of differentiation[J]. Biochim. Biophys. Acta, 1995, 1270(1): 63-72.
|
16 |
BOLDOGH I, RAMANA C V, CHEN Z, et al. Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling[J]. Cancer Res., 1998, 58(17):3950-3956.
|
17 |
WARREN K E, GURURANGAN S, GEYER J R, et al.. A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a pediatric brain tumor consortium study[J]. J. Neurooncol., 2012, 106(3): 643-649.
|
18 |
ROOS W P, BATISTA L F, NAUMANN S C, et al.. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine[J]. Oncogene, 2007, 26(2): 186-197.
|
19 |
BARVAUX V A, LORIGAN P, RANSON M, et al.. Sensitization of a human ovarian cancer cell line to temozolomide by simultaneous attenuation of the Bcl-2 antiapoptotic protein and DNA repair by O6-alkylguanine-DNA alkyltransferase[J]. Mol. Cancer Ther., 2004, 3(10): 1215-1220.
|
20 |
HERMISSON M, KLUMPP A, WICK W, et al.. O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells[J]. J. Neurochem., 2006, 96(3): 766-776.
|
21 |
WILSON D M, BARSKY D. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA[J]. Mutat. Res., 2001, 485(4): 283-307.
|
22 |
CHAKRAVARTI D, IBEANU G C, TANO K, et al. Cloning and expression in Escherichia coli of a human cDNA encoding the DNA repair protein N-methylpurine-DNA glycosylase[J]. J. Biol. Chem., 1991, 266(24): 15710-15715.
|
23 |
ENGELWARD B P, WEEDA G, WYATT M D, et al.. Base excision repair deficient mice lacking the Aag alkyladenine DNA glycosylase[J]. Proc. Natl. Acad. Sci. USA, 1997, 94(24): 13087-13092.
|
24 |
THANASUPAWAT T, NATARAJAN S, ROMMEL A,, et al.. Dovitinib enhances temozolomide efficacy in glioblastoma cells[J]. Mol. Oncol., 2017, 11(8): 1078-1098.
|
25 |
GUPTA S K, KIZILBASH S H, CARLSON B L, et al.. Delineation of MGMT hypermethylation as a biomarker for veliparib-mediated temozolomide-sensitizing therapy of glioblastoma[J/OL]. J. Natl. Cancer. Inst., 2015, 108(5): djv369[2021-09-30]. .
|
26 |
DANTZER F, DE LA RUBIA G, MÉNISSIER-DE M J, et al.. Base excision repair is impaired in mammalian cells lacking poly(ADP-ribose) polymerase-1[J]. Biochemistry, 2000, 39(25): 7559-7569.
|
27 |
CALDECOTT K W, AOUFOUCHI S, JOHNSON P, et al.. XRCC1 polypeptide interacts with DNA polymerase beta and possibly poly (ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro[J]. Nucl. Acids Res., 1996, 24(22): 4387-4394.
|
28 |
PRASAD R, LAVRIK O I, KIM S J, et al.. DNA polymerase β-mediated long patch base excision repair poly(ADP-ribose) polymerase-1 stimulates strand displacement dna synthesis[J]. J. Biol. Chem., 2001, 276(35): 32411-32414.
|
29 |
DIANOVA I I, SLEETH K M, LALLINSONet al S.. XRCC1-DNA polymerase interaction is required for efficient base excision repair[J]. Nucl. Acids Res., 2004, 32(8): 2550-2555.
|
30 |
PARSONS J L, DIANOVA I I, ALLINSON S L, et al.. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts[J]. FEBS J., 2010, 272(8):2012-2021.
|
31 |
SARKARIA J N, KITANGE G J, JAMES C D, et al.. Mechanisms of chemoresistance to alkylating agents in malignant glioma[J]. Clin. Cancer Res., 2008, 14(10): 2900-2908.
|
32 |
MCFALINE-FIGUEROA J L, BRAUN C J, STANCIU M, et al.. Minor changes in expression of the mismatch repair protein msh2 exert a major impact on glioblastoma response to temozolomide[J]. Cancer Res., 2015, 75(15): 3127-3138.
|
33 |
STRUVE N, BINDER Z A, STEAD L F, et al. EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma[J]. Oncogene, 2020, 39(15): 3041-3055.
|
34 |
STRUVE N, BINDER Z A, STEAD L F, et al.. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs[J]. Cell, 1994, 77(4): 491-502.
|
35 |
刘晨,安晓霞,张凡,等.肿瘤干细胞相关基因ABCB1、ABCG2表达与宫颈上皮恶变及发展关系的研究[J].现代妇产科进展,2012(04):294-297.
|
36 |
MARIS J, HOGARTY M, BAGATELL R, et al.. Neuroblastoma[J]. Lancet, 2007, 369(9579): 2106-2120.
|